ecabet has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, S; Liu, Q; Munakata, A; Nakaji, S; Shimoyama, T; Sugawara, K | 1 |
Jung, HC; Kim, JM; Kim, JS; Kim, N; Oh, YK; Song, IS | 1 |
2 other study(ies) available for ecabet and interleukin-8
Article | Year |
---|---|
Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
Topics: Abietanes; Anti-Bacterial Agents; Anti-Ulcer Agents; Diterpenes; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Luminescent Measurements; Neutrophils; Reactive Oxygen Species | 2001 |
Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
Topics: Abietanes; Blotting, Western; Cell Line; Electrophoretic Mobility Shift Assay; Epithelial Cells; Gastric Mucosa; Gene Expression Regulation; Genes, Reporter; Helicobacter pylori; Humans; I-kappa B Proteins; Interleukin-8; Luciferases; Microbial Sensitivity Tests; NF-kappa B; NF-KappaB Inhibitor alpha; RNA, Messenger; Transcription, Genetic | 2003 |